$EYPT

EyePoint, Inc.

Nasdaq · Technology · Laboratory Analytical Instruments · Watertown, MA

EYPT chart

What traders are saying about $EYPT

Latest posts

EyePoint, Inc. news

EyePoint, Inc. key financials

USD2025202420232022
Revenue$31.4M$43.3M$46.0M$41.4M
Net income-$232.0M-$130.9M-$70.8M-$102.3M
Diluted EPS$-3.17$-2.32$-1.82$-2.74
Total assets (year end)$364.0M$418.5M$355.2M$180.4M
Cash and equivalents (year end)$101.8M$99.7M$281.3M$95.6M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K

About EyePoint, Inc.

Ticker
EYPT (Nasdaq)
Industry
Laboratory Analytical Instruments
Headquarters
Watertown, MA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1314102
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD

Frequently asked questions

What exchange is EyePoint, Inc. listed on?

EyePoint, Inc. trades on the Nasdaq under the ticker symbol EYPT.

What industry is EyePoint, Inc. in?

EyePoint, Inc. is classified by the SEC under "Laboratory Analytical Instruments", part of the Technology sector on StockTweeting.

Where is EyePoint, Inc. headquartered?

EyePoint, Inc.'s business address on file with the SEC is in Watertown, MA.

When does EyePoint, Inc.'s fiscal year end?

EyePoint, Inc.'s fiscal year ends on December 31.

How much revenue did EyePoint, Inc. report?

EyePoint, Inc. reported $31.4M in revenue for calendar year 2025, according to its SEC filings.